Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Nicholas Light(University of Toronto), Adam Shlien, Matthew Zatzman(University of Toronto), Fabio Fuligni(Hospital for Sick Children), Sasha Blay(Hospital for Sick Children), Vallijah Subasri(University of Toronto), Jordan R. Hansford, Gino R. Somers(University of Toronto), Joshua D. Schiffman(University of Utah), Larissa Waldman(Sunnybrook Health Science Centre), Ayush Attery(Weizmann Institute of Science), Himanshi Agarwal(Weizmann Institute of Science), Lisa M. Abegglen(University of Utah), Sam Behjati(University of Cambridge), Richard de Borja, Jonathan L. Finlay(Nationwide Children's Hospital), Rupal Hatkar(University of Toronto), Nathaniel D. Anderson(Wellcome Sanger Institute), Ludmil B. Alexandrov(UC San Diego Health System), Mehdi Layeghifard(Hospital for Sick Children), David Malkin(Hospital for Sick Children), Ana Novokmet(Hospital for Sick Children), David Chen(Hospital for Sick Children), Daniel J. Albertson(University of Utah), James Tran, Anita Villani(University of Toronto), Varda Rotter(Weizmann Institute of Science), Moritz Gerstung(European Bioinformatics Institute)
Cited by 46
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k